Feb 01, 2021
Q BioMed Expands Strontium89 Reach Through Agreement with UroGPO, the Largest Group Purchasing Organization for Independent Urology Clinics in the US
Jan 27, 2021
Q BioMed's Uttroside-B Receives U.S. FDA Orphan Drug Designation in the Treatment of Liver Cancer
Jan 26, 2021
Q BioMed's Uttroside-B Receives Additional Patent Coverage in Canada and Japan
Dec 21, 2020
Q BioMed Technology Partner Mannin Research Inc. Announced as Member of Canadian National COVID-19 Consortium
Nov 20, 2020
Q BioMed's Strontium89 Advertisement "Unfinished Business" Selected for Prestigious Ads of the World's Best Creative Campaigns
Nov 16, 2020
Q BioMed's Uttroside-B Receives U.S. Patent in Treatment of Liver Cancer
Sep 15, 2020
Q BioMed Announces Strontium89 Initial Uptake and Momentum in US and Europe
Aug 26, 2020
Q BioMed Announces Initiation of GMP Production of Novel COVID-19 Therapeutic for Clinical Trial Program
Jul 22, 2020
Q Biomed to Scale up Production of Uttroside-B, a Novel Chemotherapeutic for Liver Cancer, in Preparation for IND Filing
Jun 30, 2020
Q BioMed Updates Shareholders
Jun 12, 2020
QBioMed to Support and Exhibit at Living Beyond Breast Cancer 2020 Virtual Conference on June 13-14, 2020
Apr 22, 2020
Q BioMed Initiates Rapid Development of Novel COVID-19 Therapeutics
Apr 07, 2020
Q BioMed Enters into a Financial Restructuring of Approximately $7,800,000 Consisting of $4,000,000 New Cash and a Minimum of $3,800,000 of Debt Conversion
Mar 31, 2020
Q BioMed Adds to Leadership Team With Global Head of Regulatory Affairs
Mar 30, 2020
Q BioMed Expands Leadership Team With Chief Commercial Officer
Feb 04, 2020
Q BioMed Partner Mannin Research Developing Potential Treatment for Patients Infected with Coronavirus and Other Infectious Diseases
Nov 26, 2019
Q BioMed Technology Partner Mannin Research Inc. Presents Data Showing Potential Treatment to Protect the Kidney in Acute Kidney Injury Using Mannin Tie2 Activator
Nov 20, 2019
Q BioMed Announces FDA Approval
Nov 05, 2019
Q BioMed Announces $7.5M Grant Benefiting its Preclinical Product Development Pipeline
Oct 02, 2019
Q BioMed Announces Legal Settlement and Acquisition of FDA Approved Non-Opioid Metastatic Cancer Pain Drug